Moreover, E2 and P4 monotherapies equally reduced the numbers of malignant lesions and colonic testosterone levels alongside AR and ERα protein expression, whilst upregulated ERβ and PGR and promoted cell cycle arrest and apoptosis in male mice, as well as in human male colon cancer cell lines. The gene discussed is ESR2; the disease is malignant colon neoplasm.